Genprex’s Reqorsa combo secures Canadian patent for lung cancer
Genprex has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for a patent related to the…
23 Jun 2026
BIO 2026: Drug manufacturers band together to tackle employment challenges
US-based drugmakers are meeting rising demand not by competing for local talent, but by collaborating through trade associations to support the next generation of workers. At the 2026 BIO conference…
23 Jun 2026
Lilly and BioArctic sign deal to develop neurodegenerative therapy
Eli Lilly and Company has signed a research and collaboration agreement with Swedish biopharmaceutical company BioArctic to develop a potential treatment for neurodegenerative diseases. The partnership will combine BioArctic’s BrainTransporter…
22 Jun 2026
AbbVie deepens immunology legacy in $10.9bn Apogee buyout
AbbVie has agreed to acquire Apogee Therapeutics for $10.9bn, potentially further fortifying its legacy in the immunology space and marking another sizeable investment into the disease area as it garners…
22 Jun 2026
HLTH Europe 2026: enriching the patient journey with health technologies
With the pharma, biotech and medtech sectors debuting new and potentially life-changing innovations for patients at a rapid pace, many are now gaining access to care that was once thought…
22 Jun 2026
Moderna’s mRNA flu vaccine passes FDA AdCom, review underway
Moderna’s mRNA vaccine for influenza prevention has passed a US Food and Drug Administration (FDA) Advisory Committee (AdCom) meeting, meaning the company has successfully navigated a volatile backdrop with the…
22 Jun 2026
Sun Pharma to acquire Innovcare Lifesciences for $28.7m
Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m). According to a regulatory filing, Sun Pharma will buy the entire issued…